Displaying publications 21 - 40 of 211 in total

Abstract:
Sort:
  1. Khairudin NF, Sukri MFF, Khavarian M, Mohamed AR
    Beilstein J Nanotechnol, 2018;9:1162-1183.
    PMID: 29719767 DOI: 10.3762/bjnano.9.108
    Dry reforming of methane (DRM) is one of the more promising methods for syngas (synthetic gas) production and co-utilization of methane and carbon dioxide, which are the main greenhouse gases. Magnesium is commonly applied in a Ni-based catalyst in DRM to improve catalyst performance and inhibit carbon deposition. The aim of this review is to gain better insight into recent developments on the use of Mg as a support or promoter for DRM catalysts. Its high basicity and high thermal stability make Mg suitable for introduction into the highly endothermic reaction of DRM. The introduction of Mg as a support or promoter for Ni-based catalysts allows for good metal dispersion on the catalyst surface, which consequently facilitates high catalytic activity and low catalyst deactivation. The mechanism of DRM and carbon formation and reduction are reviewed. This work further explores how different constraints, such as the synthesis method, metal loading, pretreatment, and operating conditions, influence the dry reforming reactions and product yields. In this review, different strategies for enhancing catalytic activity and the effect of metal dispersion on Mg-containing oxide catalysts are highlighted.
    Matched MeSH terms: Magnesium
  2. Shunmugaperumal T, Ramamurthy S
    Drug Dev Ind Pharm, 2012 Mar 12.
    PMID: 22409156 DOI: 10.3109/03639045.2012.665459
    Magnesium fluoride (MgF(2)) nanoparticles-stabilized oil-in-water nanosized emulsion was prepared and assessed for its antiadherent and antibiofilm activities over glass coupons against pathogenic microorganisms like Escherichia coli and Staphylococcus aureus.
    Matched MeSH terms: Magnesium Compounds
  3. Tan KH
    Med J Malaysia, 1984 Sep;39(3):246-9.
    PMID: 6100563
    The severity of pulmonary aspiration depends mainly on the acidity of the aspirate. Mist magnesium trisilicate (MMT) has been used for many years at the maternity unit in General Hospital, Kuala Lumpur, to neutralise the acidic gastric contents in all obstetric patients requiring caesarian section. This preliminary study shows that a single dose of 15 mls of MMT before general anaesthesia raises the intragastric pH to above the critical level of 2.5 in 80% of the patients. Recently there have been doubts over the protective role of MMT. Sodium citrate which is the other antacid available may be a better alternative.
    Matched MeSH terms: Magnesium/administration & dosage; Magnesium/therapeutic use*; Magnesium Silicates*
  4. Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L
    Cochrane Database Syst Rev, 2019 09 09;9:CD011358.
    PMID: 31498421 DOI: 10.1002/14651858.CD011358.pub3
    BACKGROUND: Sickle cell disease is an autosomal recessive inherited haemoglobinopathy which causes painful vaso-occlusive crises due to sickle red blood cell dehydration. Vaso-occlusive crises are common painful events responsible for a variety of clinical complications; overall mortality is increased and life expectancy decreased compared to the general population. Experimental studies suggest that intravenous magnesium has proven to be well-tolerated in individuals hospitalised for the immediate relief of acute (sudden onset) painful crisis and has the potential to decrease the length of hospital stay. Some in vitro studies and open studies of long-term oral magnesium showed promising effect on pain relief but failed to show its efficacy. The studies show that oral magnesium therapy may prevent sickle red blood cell dehydration and prevent recurrent painful episodes. There is a need to access evidence for the impact of oral and intravenous magnesium effect on frequency of pain, length of hospital stay and quality of life. This is an updated version of the review.

    OBJECTIVES: To evaluate the effects of short-term intravenous magnesium on the length of hospital stay and quality of life in children and adults with sickle cell disease. To determine the effects of long-term oral magnesium therapy on the frequency of painful crises and the quality of life in children and adults with sickle cell disease.

    SEARCH METHODS: We searched the Cochrane Haemoglobinopathies Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books.Date of last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register: 03 February 2019.Date of last search of other resources (clinical trials registries): 04 April 2019.

    SELECTION CRITERIA: We searched for published and unpublished randomized controlled studies of oral or intravenous magnesium compared to placebo or no magnesium.

    DATA COLLECTION AND ANALYSIS: Authors independently assessed the study quality and extracted the data using standard Cochrane methodologies.

    MAIN RESULTS: We included five randomized placebo-controlled studies with a total of 386 participants (aged three to 53 years). Of these, two shorter parallel studies (n = 306) compared intravenous magnesium sulphate to placebo (normal saline) for admission to hospital due to a vaso-occlusive crisis, for which we were able to analyse data. The quality of evidence was moderate for studies in this comparison, mainly due to limitations due to risk of bias and imprecision. Two of the three longer-term studies comparing oral magnesium pidolate to placebo had a cross-over design. The third was a parallel factorial study which compared hydroxyurea and oral magnesium to each other and to placebo over a longer period of time; we only present the comparison of oral magnesium to placebo from this study. The quality of evidence was very low with uncertainty of the estimation.The eight-hourly dose levels in the two studies of intravenous magnesium were different; one used 100 mg/kg while the second used 40 mg/kg. Only one of these studies (n = 104) reported the mean daily pain score while hospitalised (a non-significant difference between groups, moderate quality evidence). The second study (n = 202) reported a number of child- and parent-reported quality of life scores. None of the scores showed any difference between treatment groups (low quality evidence). Data from one study (n = 106) showed no difference in length of stay in hospital between groups (low quality evidence). Both studies reported on adverse events, but not defined by severity as we had planned. One study showed significantly more participants receiving intravenous magnesium experienced warmth at infusion site compared to placebo; there were no differences between groups for other adverse events (low quality evidence).Three studies (n = 80) compared oral magnesium pidolate to placebo. None of them reported data which we were able to analyse. One study (n = 24) reported on the number of painful days and stated there was no difference between two groups (low quality evidence). None of the studies reported on quality of life or length of hospital stay. Two studies (n = 68) reported there were no differences in levels of magnesium in either plasma or red blood cells (moderate quality evidence). Two studies (n = 56) reported adverse events. One reported episodes of mild diarrhoea and headache, all of which resolved without stopping treatment. The second study reported adverse events as gastrointestinal disorders, headache or migraine, upper respiratory infections and rash; which were all evenly distributed across treatment groups (moderate quality evidence).

    AUTHORS' CONCLUSIONS: Moderate to low quality evidence showed neither intravenous magnesium and oral magnesium therapy has an effect on reducing painful crisis, length of hospital stay and changing quality of life in treating sickle cell disease. Therefore, no definitive conclusions can be made regarding its clinical benefit. Further randomized controlled studies, perhaps multicentre, are necessary to establish whether intravenous and oral magnesium therapies have any effect on improving the health of people with sickle cell disease.

    Matched MeSH terms: Magnesium/blood; Magnesium/therapeutic use*; Magnesium Sulfate/therapeutic use
  5. Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L
    Cochrane Database Syst Rev, 2017 Apr 14;4:CD011358.
    PMID: 28409830 DOI: 10.1002/14651858.CD011358.pub2
    BACKGROUND: Sickle cell disease is an autosomal recessive inherited haemoglobinopathy which causes painful vaso-occlusive crises due to sickle red blood cell dehydration. Vaso-occlusive crises are common painful events responsible for a variety of clinical complications; overall mortality is increased and life expectancy decreased compared to the general population. Experimental studies suggest that intravenous magnesium has proven to be well-tolerated in individuals hospitalised for the immediate relief of acute (sudden onset) painful crisis and has the potential to decrease the length of hospital stay. Some in vitro studies and open studies of long-term oral magnesium showed promising effect on pain relief but failed to show its efficacy. The studies show that oral magnesium therapy may prevent sickle red blood cell dehydration and prevent recurrent painful episodes. There is a need to access evidence for the impact of oral and intravenous magnesium effect on frequency of pain, length of hospital stay and quality of life.

    OBJECTIVES: To evaluate the effects of short-term intravenous magnesium on the length of hospital stay and quality of life in children and adults with sickle cell disease. To determine the effects of long-term oral magnesium therapy on the frequency of painful crises and the quality of life in children and adults with sickle cell disease.

    SEARCH METHODS: We searched the Cochrane Haemoglobinopathies Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books.Date of last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register: 01 December 2016.Date of last search of other resources (clinical trials registries): 29 March 2017.

    SELECTION CRITERIA: We searched for published and unpublished randomized controlled studies of oral or intravenous magnesium compared to placebo or no magnesium.

    DATA COLLECTION AND ANALYSIS: Authors independently assessed the study quality and extracted the data using standard Cochrane methodologies.

    MAIN RESULTS: We included five randomized placebo-controlled studies with a total of 386 participants (aged three to 53 years). Two shorter parallel studies (n = 306) compared intravenous magnesium sulphate to placebo (normal saline) for admission to hospital due to a vaso-occlusive crisis, for which we were able to analyse data. The quality of evidence was moderate for studies presenting this comparison mainly due to limitations due to risk of bias and imprecision. Two of the three longer-term studies comparing oral magnesium pidolate to placebo had a cross-over design. The third was a parallel factorial study which compared hydroxyurea and oral magnesium to each other and to placebo over a longer period of time; we only present the comparison of oral magnesium to placebo from this study. The quality of evidence was very low with uncertainty of the estimation.The eight-hourly dose levels in the two studies of intravenous magnesium were different; one used 100 mg/kg while the second used 40 mg/kg. Only one of these studies (n = 104) reported the mean daily pain score while hospitalised (a non-significant difference between groups, moderate quality evidence). The second study (n = 202) reported a number of child- and parent-reported quality of life scores. None of the scores showed any difference between treatment groups (low quality evidence). Data from one study (n = 106) showed no difference in length of stay in hospital between groups (low quality evidence). Both studies reported on adverse events, but not defined by severity as we had planned. One study showed significantly more participants receiving intravenous magnesium experienced warmth at infusion site compared to placebo; there were no differences between groups for other adverse events (low quality evidence).Three studies (n = 80) compared oral magnesium pidolate to placebo. None of them reported data which we were able to analyse. One study (n = 24) reported on the number of painful days and stated there was no difference between two groups (low quality evidence). None of the studies reported on quality of life or length of hospital stay. Two studies (n = 68) reported there were no differences in levels of magnesium in either plasma or red blood cells (moderate quality evidence). Two studies (n = 56) reported adverse events. One reported episodes of mild diarrhoea and headache, all of which resolved without stopping treatment. The second study reported adverse events as gastrointestinal disorders, headache or migraine, upper respiratory infections and rash; which were all evenly distributed across treatment groups (moderate quality evidence).

    AUTHORS' CONCLUSIONS: Moderate to low quality evidence showed neither intravenous magnesium and oral magnesium therapy has an effect on reducing painful crisis, length of hospital stay and changing quality of life in treating sickle cell disease. Therefore, no definitive conclusions can be made regarding its clinical benefit. Further randomized controlled studies, perhaps multicentre, are necessary to establish whether intravenous and oral magnesium therapies have any effect on improving the health of people with sickle cell disease.

    Matched MeSH terms: Magnesium/adverse effects; Magnesium/blood; Magnesium/therapeutic use*; Magnesium Sulfate/therapeutic use
  6. Liau CP, Bin Ahmad M, Shameli K, Yunus WM, Ibrahim NA, Zainuddin N, et al.
    ScientificWorldJournal, 2014;2014:572726.
    PMID: 24600329 DOI: 10.1155/2014/572726
    Polyhydroxybutyrate (PHB)/polycaprolactone (PCL)/stearate Mg-Al layered double hydroxide (LDH) nanocomposites were prepared via solution casting intercalation method. Coprecipitation method was used to prepare the anionic clay Mg-Al LDH from nitrate salt solution. Modification of nitrate anions by stearate anions between the LDH layers via ion exchange reaction. FTIR spectra showed the presence of carboxylic acid (COOH) group which indicates that stearate anions were successfully intercalated into the Mg-Al LDH. The formation of nanocomposites only involves physical interaction as there are no new functional groups or new bonding formed. X-ray diffraction (XRD) and transmission electron microscopy (TEM) indicated that the mixtures of nanocomposites are intercalated and exfoliated types. XRD results showed increasing of basal spacing from 8.66 to 32.97 Å in modified stearate Mg-Al LDH, and TEM results revealed that the stearate Mg-Al LDH layers are homogeneously distributed in the PHB/PCL polymer blends matrix. Enhancement in 300% elongation at break and 66% tensile strength in the presence of 1.0 wt % of the stearate Mg-Al LDH as compare with PHB/PCL blends. Scanning electron microscopy (SEM) proved that clay improves compatibility between polymer matrix and the best ratio 80PHB/20PCL/1stearate Mg-Al LDH surface is well dispersed and stretched before it breaks.
    Matched MeSH terms: Magnesium/chemistry
  7. Anis S, Zainal ZA, Bakar MZ
    Bioresour Technol, 2013 May;136:117-25.
    PMID: 23567671 DOI: 10.1016/j.biortech.2013.02.049
    A new effective RF tar thermocatalytic treatment process with low energy intensive has been proposed to remove tar from biomass gasification. Toluene and naphthalene as biomass tar model compounds were removed via both thermal and catalytic treatment over a wide temperature range from 850 °C to 1200 °C and 450 °C to 900 °C, respectively at residence time of 0-0.7 s. Thermal characteristics of the new technique are also described in this paper. This study clearly clarified that toluene was much easier to be removed than naphthalene. Soot was found as the final product of thermal treatment of the tar model and completely removed during catalytic treatment. Radical reactions generated by RF non-thermal effect improve the tar removal. The study showed that Y-zeolite has better catalytic activity compared to dolomite on toluene and naphthalene removal due to its acidic nature and large surface area, even at lower reaction temperature of about 550 °C.
    Matched MeSH terms: Magnesium/chemistry
  8. Chua LS, Abdul-Rahman N, Rosidi B, Lee CT
    Nat Prod Res, 2013 Mar;27(4-5):314-8.
    PMID: 22468741 DOI: 10.1080/14786419.2012.676552
    A water extraction method has been used to extract plant proteins from the roots of Eurycoma longifolia harvested from Perak and Pahang, Malaysia. On the basis of the spectroscopic Bradford assay, Tongkat Ali Perak and Pahang contained 0.3868 and 0.9573 mg mL(-1) of crude protein, respectively. The crude proteins were separated by one dimensional 15% sodium dodecyl sulphate polyacrylamide gel electrophoresis into two (49.8 and 5.5 kD) and four (49.8, 24.7, 21.1 and 5.5 kD) protein spots for Tongkat Ali Perak and Pahang, respectively. Isoleucine was present in the highest concentration significantly. Both plant samples showed differences in the mineral and trace element profiles, but the minerals calcium, magnesium and potassium were present in the highest concentration. The highly concerned toxic metals such as arsenic and lead were not detected.
    Matched MeSH terms: Magnesium/analysis
  9. Rahman NA, Olutoye MA, Hameed BH
    Bioresour Technol, 2011 Oct;102(20):9749-54.
    PMID: 21855332 DOI: 10.1016/j.biortech.2011.07.023
    The potential of Mg(x)Co(2-)(x)O(2) as heterogeneous reusable catalyst in transesterification of palm oil to methyl ester was investigated. The catalyst was prepared via co-precipitation of the metal hydroxides at different Mg-Co ratios. Mg(1.7)Co(0.3)O(2) catalyst was more active than Mg(0.3)Co(1.7)O(2) in the transesterification of palm oil with methanol. The catalysts calcined at temperature 300 °C for 4 h resulted in highly active oxides and the highest transesterification of 90% was achieved at methanol/oil molar ratio of 9:1, catalyst loading of 5.00 wt.%, reaction temperature of 150 °C and reaction time of 2 h. The catalyst could easily be removed from reaction mixture, but showed 50% decrease in activity when reused due to leaching of active sites.
    Matched MeSH terms: Magnesium Oxide/chemistry*
  10. Maleki-Ghaleh H, Hafezi M, Hadipour M, Nadernezhad A, Aghaie E, Behnamian Y, et al.
    PLoS One, 2015;10(9):e0138454.
    PMID: 26383641 DOI: 10.1371/journal.pone.0138454
    In the current study, a sol-gel-synthesized tricalcium magnesium silicate powder was coated on Ti-6Al-4V alloys using plasma spray method. Composition of feed powder was evaluated by X-ray diffraction technique before and after the coating process. Scanning electron microscopy and atomic force microscopy were used to study the morphology of coated substrates. The corrosion behaviors of bare and coated Ti-6Al-4V alloys were examined using potentiodynamic polarization test and electrochemical impedance spectroscopy in stimulated body fluids. Moreover, bare and coated Ti-6Al-4V alloys were characterized in vitro by culturing osteoblast and mesenchymal stem cells for several days. Results demonstrated a meaningful improvement in the corrosion resistance of Ti-6Al-4V alloys coated with tricalcium magnesium silicate compared with the bare counterparts, by showing a decrease in corrosion current density from 1.84 μA/cm2 to 0.31 μA/cm2. Furthermore, the coating substantially improved the bioactivity of Ti-6Al-4Valloys. Our study on corrosion behavior and biological response of Ti-6Al-4V alloy coated by tricalcium magnesium silicate proved that the coating has considerably enhanced safety and applicability of Ti-6Al-4V alloys, suggesting its potential use in permanent implants and artificial joints.
    Matched MeSH terms: Magnesium/chemistry*
  11. Lim SL, Wu TY
    J Agric Food Chem, 2016 Mar 2;64(8):1761-9.
    PMID: 26844586 DOI: 10.1021/acs.jafc.6b00531
    The valorization process involves transforming low-value materials such as wastes into high-value-added products. The current study aims to determine the potential of using a valorization process such as vermicomposting technology to convert palm oil mill byproduct, namely, decanter cake (DC), into organic fertilizer or vermicompost. The maturity of the vermicompost was characterized through various chemical and instrumental characterization to ensure the end product was safe and beneficial for agricultural application. The vermicomposting of DC showed significantly higher nutrient recovery and decreases in C:N ratio in comparison with the controls, particularly in the treatment with 2 parts DC and 1 part rice straw (w/w) (2DC:1RS). 2DC:1RS vermicompost had a final C:N ratio of 9.03 ± 0.12 and reasonably high levels of calcium (1.13 ± 0.05 g/kg), potassium (25.47 ± 0.32 g/kg), magnesium (4.87 ± 0.19 g/kg), sodium (7.40 ± 0.03 g/kg), and phosphorus (3.62 ± 0.27 g/kg). In addition, instrumental characterization also revealed a higher degree of maturity in the vermicompost. Ratios of 2921:1633 and DTG2:DTG3 also showed significant linear correlations with the C:N ratio, implying that those ratios could be used to characterize the progression of vermicompost maturity during the valorization process of DC.
    Matched MeSH terms: Magnesium/analysis
  12. Abdullah H, Pearson GJ
    Asian J Aesthet Dent, 1993 Jul;1(2):91-4.
    PMID: 7921802
    The effect of temperature change on the working and setting time of a glass ionomer luting cement and a resin luting cement was measured using the oscillating rheometer. The time taken for each cement to set was calculated from the chart recordings. It was observed that as the temperature increased, the working and setting time of both materials decreased. However, the reduction was much more marked for the dual curing resin cement.
    Matched MeSH terms: Magnesium Oxide/chemistry*
  13. Nik Nur Syafika Pahri, Nur Huda Syazwani Jafri, Husna Ahmad Tajuddin, Yusilawati Ahmad Nor
    MyJurnal
    Effective treatment of wastewater is crucial in order to achieve a sustainable development. For instance, highly efficient treatment processes with low capital requirements are the major prerequisite for implementation of the advanced wastewater treatment operations. Among various available treatment methods, the application of coagulation-flocculation process by using natural coagulant; chitosan has vast advantages such as low operating cost, environmental friendly and highly effective in the wastewater treatment operations. The application of nanotechnology in numerous treatment techniques are considered as the most significant advances in water and wastewater treatment practices. The utilization of magnesium oxide (MgO) as nano-adsorbent has recently gained attention as a potential treatment method in water remediation particularly for treating effluents with high amount of organic dyes and heavy metals due to its high treatment efficiency, low cost, versatility and environment compatibility. The purpose of this study was to determine the effectiveness of coagulation-flocculation process when using novel coagulant in which MgO coated with chitosan by investigating the percentage removal of several significant parameters which were turbidity, chemical oxygen demand (COD) and suspended solid. The removal efficiencies were determined throughout a series of experiments carried out using a standard jar test procedure in which three different coagulants; chitosan, MgO coated with chitosan and MgO were tested on water samples taken from Sg. Pusu. In addition, a set of experiments was designed using response surface methodology (RSM) in order to optimize adsorption of chitosan into MgO. The experiments were conducted at various concentrations of chitosan (10-30 mg/ml) and selected MgO dosage ranges (10-30 mg). From the obtained results, it was found that chitosan-MgO coagulant has good removal efficiencies of turbidity, chemical oxygen demand (COD) and suspended solids at 92%, 91%, and 98% respectively from the optimization of adsorption of chitosan-MgO. The MgO coated with chitosan is the best coagulant in this study compared to chitosan and MgO alone because of the ability of treating the river water with up to 90 % removal for all the main parameters. The results showed that coagulation-flocculation is effective as a treatment for treating river water.
    Matched MeSH terms: Magnesium; Magnesium Oxide
  14. Md Saad AP, Prakoso AT, Sulong MA, Basri H, Wahjuningrum DA, Syahrom A
    Biomech Model Mechanobiol, 2019 Jun;18(3):797-811.
    PMID: 30607641 DOI: 10.1007/s10237-018-01115-z
    This study employs a computational approach to analyse the impact of morphological changes on the structural properties of biodegradable porous Mg subjected to a dynamic immersion test for its application as a bone scaffold. Porous Mg was immersed in a dynamic immersion test for 24, 48, and 72 h. Twelve specimens were prepared and scanned using micro-CT and then reconstructed into a 3D model for finite element analysis. The structural properties from the numerical simulation were then compared to the experimental values. Correlations between morphological parameters, structural properties, and fracture type were then made. The relative losses were observed to be in agreement with relative mass loss done experimentally. The degradation rates determined using exact (degraded) surface area at particular immersion times were on average 20% higher than the degradation rates obtained using original surface area. The dynamic degradation has significantly impacted the morphological changes of porous Mg in volume fraction, surface area, and trabecular separation, which in turn affects its structural properties and increases the immersion time.
    Matched MeSH terms: Magnesium/chemistry*
  15. Ahmadian A, Bilal M, Khan MA, Asjad MI
    Sci Rep, 2020 Nov 02;10(1):18776.
    PMID: 33139760 DOI: 10.1038/s41598-020-75905-w
    A three dimensional (3D) numerical solution of unsteady, Ag-MgO hybrid nanoliquid flow with heat and mass transmission caused by upward/downward moving of wavy spinning disk has been scrutinized. The magnetic field has been also considered. The hybrid nanoliquid has been synthesized in the presence of Ag-MgO nanoparticles. The purpose of the study is to improve the rate of thermal energy transmission for several industrial purposes. The wavy rotating surface increases the heat transmission rate up to 15%, comparatively to the flat surface. The subsequent arrangement of modeled equations is diminished into dimensionless differential equation. The obtained system of equations is further analytically expounded via Homotopy analysis method HAM and the numerical Parametric continuation method (PCM) method has been used for the comparison of the outcomes. The results are graphically presented and discussed. It has been presumed that the geometry of spinning disk positively affects the velocity and thermal energy transmission. The addition of hybrid nanoparticles (silver and magnesium-oxide) significantly improved thermal property of carrier fluid. It uses is more efficacious to overcome low energy transmission. Such as, it provides improvement in thermal performance of carrier fluid, which play important role in power generation, hyperthermia, micro fabrication, air conditioning and metallurgical field.
    Matched MeSH terms: Magnesium; Magnesium Oxide
  16. Affendi, A.F., Hasmaliza, M., Srimala, S.
    MyJurnal
    In these studies, cordierite was mechanically synthesized after a sol-gel process. The effect of milling time of cordierite was investigated. Aluminium nitrate nonahydrate, magnesium nitrate hexahydrate and tetraethylorthosilicate (TEOS) were used as starting materials. Gels obtained were mechanically activated in planetary ball mill by at 300rpm grinding speed and grinding time (15min, 30min, 45min and 60min). Powders produced were characterized by X-Ray Diffraction (XRD) and Field Emission Scanning Electron Microscope (FESEM) and Energy Dispersive X-Ray (EDX). XRD analysis proved that α-cordierite was formed at lower temperature (1200°C) as compliment to without grinding, whereby it is formed at1300°C. FESEM analysis shows the size of the cordierite were in submicron scale. EDX analysis proved that magnesium, aluminium, silicon and oxygen are elements existed in cordierite.
    Matched MeSH terms: Magnesium; Magnesium Compounds
  17. Sahibin AR, Shamshuddin J, Fauziah CI, Radziah O, Wan Mohd Razi I, Enio MSK
    Sci Total Environ, 2019 Feb 20;652:573-582.
    PMID: 30368186 DOI: 10.1016/j.scitotenv.2018.10.232
    A study was conducted in an oil palm plantation in Peninsular Malaysia to elucidate the effects of applying Magnesium Rich Synthetic Gypsum (MRSG), a by-product of chemical plant, on the chemical properties of soil, the uptake of heavy metals by the palm trees, the oil quality and its impact on the surrounding environment. The results showed that MRSG application onto soil cropped to oil palm could bring positive impact in terms of soil chemical properties and oil palm production. The quality of the oil was not significantly affected by the continuous MRSG application as shown by the low heavy metals and trace elements of concern content (Cu: 0.062 mg/kg; Fe: 2.10 mg/kg; Mn: 1.93 mg/kg; Pb: 0.006 mg/kg; Zn: 0.103 mg/kg; Cr: 0.354 mg/kg; Ni: 0.037 mg/kg). From the I-geochem index, the soil was found to have values ranging from -3.81 to -1.03 which is considered as uncontaminated. Further, its application did not result in negative impact on the surrounding environment; hence, the quality of the soil and surface water in the plantation and/or the surrounding area remained intact. Phytotoxic elements in the oil palm tissue (As: 0.12 mg/kg; Se: 0.05 mg/kg; Zn: 1.48 mg/kg; Ce: 0.47 mg/kg; La: 0.26 mg/kg; Sr: 3.03 mg/kg) and cytotoxic elements in the oil were below the acceptable limit. Based on the results of the Environmental Monitoring out during the period of the study, it was concluded that application of the by-product of the chemical plant as a source of Mg to enhance soil fertility in the oil palm plantation was considered safe and sustainable. The effects of applying MRSG and Chinese kieserite was almost similar. So, MRSG can be used as a possible source of Mg to replace Chinese kieserite for oil palm production on the Ultisols in Peninsular Malaysia.
    Matched MeSH terms: Magnesium/chemistry*
  18. Aziz SB, Karim WO, Brza MA, Abdulwahid RT, Saeed SR, Al-Zangana S, et al.
    Int J Mol Sci, 2019 Oct 23;20(21).
    PMID: 31652832 DOI: 10.3390/ijms20215265
    In this work, analysis of ion transport parameters of polymer blend electrolytes incorporated with magnesium trifluoromethanesulfonate (Mg(CF3SO3)2) was carried out by employing the Trukhan model. A solution cast technique was used to obtain the polymer blend electrolytes composed of chitosan (CS) and poly (2-ethyl-2-oxazoline) (POZ). From X-ray diffraction (XRD) patterns, improvement in amorphous phase for the blend samples has been observed in comparison to the pure state of CS. From impedance plot, bulk resistance (Rb) was found to decrease with increasing temperature. Based on direct current (DC) conductivity (σdc) patterns, considerations on the ion transport models of Arrhenius and Vogel-Tammann-Fulcher (VTF) were given. Analysis of the dielectric properties was carried out at different temperatures and the obtained results were linked to the ion transport mechanism. It is demonstrated in the real part of electrical modulus that chitosan-salt systems are extremely capacitive. The asymmetric peak of the imaginary part (Mi) of electric modulus indicated that there is non-Debye type of relaxation for ions. From frequency dependence of dielectric loss (ε″) and the imaginary part (Mi) of electric modulus, suitable coupling among polymer segmental and ionic motions was identified. Two techniques were used to analyze the viscoelastic relaxation dynamic of ions. The Trukhan model was used to determine the diffusion coefficient (D) by using the frequency related to peak frequencies and loss tangent maximum heights (tanδmax). The Einstein-Nernst equation was applied to determine the carrier number density (n) and mobility. The ion transport parameters, such as D, n and mobility (μ), at room temperature, were found to be 4 × 10-5 cm2/s, 3.4 × 1015 cm-3, and 1.2 × 10-4 cm2/Vs, respectively. Finally, it was shown that an increase in temperature can also cause these parameters to increase.
    Matched MeSH terms: Magnesium/chemistry
  19. Saifullah B, Arulselvan P, El Zowalaty ME, Tan WS, Fakurazi S, Webster TJ, et al.
    Int J Nanomedicine, 2021;16:7035-7050.
    PMID: 34703226 DOI: 10.2147/IJN.S297040
    Introduction: Mycobacterium tuberculosis infections are associated with severe local inflammatory reactions, which may be life-threatening and lead to tuberculosis pathogenesis and associated complications. Inorganic nanolayers have been vastly exploited for biomedical applications (especially in drug delivery) because of their biocompatible and biodegradable nature with the ability to release a drug in a sustained manner. Herein, we report a new nanodelivery system of inorganic nanolayers based on magnesium layered hydroxides (MgLH) and a successfully intercalated anti-tuberculosis drug para-aminosalicylic acid (PAS).

    Methods: The designed anti-tuberculosis nanodelivery composite, MgLH-PAS, was prepared by a novel co-precipitation method using MgNO3 as well MgO as starting materials.

    Results: The designed nano-formulation, PAS-MgLH, showed good antimycobacterial and antimicrobial activities with significant synergistic anti-inflammatory effects on the suppression of lipopolysaccharide (LPS) stimulated inflammatory mediators in RAW 264.7 macrophages. The designed nano-formulation was also found to be biocompatible with human normal lung cells (MRC-5) and 3T3 fibroblast cells. Furthermore, the in vitro release of PAS from PAS-MgLH was found to be sustained in human body simulated phosphate buffer saline (PBS) solutions of pH 7.4 and pH 4.8.

    Discussion: The results of the present study are highly encouraging for further in vivo studies. This new nanodelivery system, MgLH, can be exploited in the delivery of other drugs and in numerous other biomedical applications as well.

    Matched MeSH terms: Magnesium; Magnesium Hydroxide
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links